BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Daryani NE, Daryani NE, Alavian SM, Zare A, Fereshtehnejad SM, Keramati MR, Pashaei MR, Habibollahi P. Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings. World J Gastroenterol 2010; 16(33): 4169-4175 [PMID: 20806434 DOI: 10.3748/wjg.v16.i33.4169]
URL: https://www.wjgnet.com/1948-5182/full/v16/i33/4169.htm
Number Citing Articles
1
Hüseyin Saadettin Uslusoy, Selim Giray Nak, Macit Gülten. Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitisWorld Journal of Hepatology 2011; 3(8): 219-227 doi: 10.4254/wjh.v3.i8.219
2
Mohammad Ebrahim Ghamar-Chehreh, Mohsen Amini, Hossein Khedmat, Seyed Moayed Alavian, Fatemeh Daraei, Reza Mohtashami, Reza Hadi, Bent-Al-Hoda Beyram, Saeed Taheri. Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver diseaseAsian Pacific Journal of Tropical Biomedicine 2012; 2(9): 702 doi: 10.1016/S2221-1691(12)60213-5
3
Guangda Xin, Shaoyou Qin, Song Wang, Xu Wang, Yonggui Zhang, Jiangbin Wang. Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathwayExperimental Biology and Medicine 2015; 240(10): 1279 doi: 10.1177/1535370215570189
4
Habibullah Aktas, Goksen Ertugrul, Muharrem Parlak, Mehmet Unal. Long‐term isotretinoin use does not cause parenchymal liver change: Ultrasonographic study in 50 patientsDermatologic Therapy 2019; 32(5) doi: 10.1111/dth.13012
5
Foteini Athanasopoulou, Michail Manolakakis, Santiago Vernia, Nazila Kamaly. Nanodrug delivery systems for metabolic chronic liver diseases: advances and perspectivesNanomedicine 2023; 18(1): 67 doi: 10.2217/nnm-2022-0261
6
Yun-Hee Lee, Sou Hyun Kim, Sang-Nam Kim, Hyun-Jung Kwon, Jeong-Dong Kim, Ji Youn Oh, Young-Suk Jung. Sex-specific metabolic interactions between liver and adipose tissue in MCD diet-induced non-alcoholic fatty liver diseaseOncotarget 2016; 7(30): 46959 doi: 10.18632/oncotarget.10506
7
Anđela Milićević, Nevena Lazović, Nada Tomanović. Pathohistological characteristics of steatohepatitis on needle biopsy sample from 100 patientsMedicinski podmladak 2019; 70(1): 34 doi: 10.5937/mp70-18029
8
Arsia Jamali, Shahrokh Karbalai, Ghazale Tefagh, Raika Jamali, Ayat Ahmadi. The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical TrialMiddle East Journal of Digestive Diseases 2022; 14(1): 85 doi: 10.34172/mejdd.2022.260
9
Sylvette Ayala-Peña, Carlos A. Torres-Ramos. Aging2014; : 39 doi: 10.1016/B978-0-12-405933-7.00004-4
10
Jane Knöchel, Linnéa Bergenholm, Eman Ibrahim, Stergios Kechagias, Sara Hansson, Mathias Liljeblad, Patrik Nasr, Björn Carlsson, Mattias Ekstedt, Sebastian Ueckert. A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohortsCPT: Pharmacometrics & Systems Pharmacology 2023; 12(12): 2038 doi: 10.1002/psp4.13052